Log In
Print
BCIQ
Print
Print this Print this
 

mGluR4 PAM, PXT2331 (formerly DT1687)

  Manage Alerts
Collapse Summary General Information
Company Domain Therapeutics S.A.
DescriptionSmall molecule positive allosteric modulator (PAM) of metabotropic glutamate receptor subtype 4 (mGluR4)
Molecular Target Metabotropic glutamate receptors (mGluR)
Mechanism of ActionMetabotropic glutamate receptor (mGluR) modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner

Prexton Therapeutics S.A.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today